Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Gastroenterology. 2008 Feb 13;134(5):1360–1368. doi: 10.1053/j.gastro.2008.02.014

Table 2.

Treatment Outcomes

End point Terlipressin n (%) Placebo n (%) P value
All patients (n = 56) (n = 56)
 Treatment success at day 14 14 (25.0) 7 (12.5) .093
 HRS reversal 19 (33.9) 7 (12.5) .008
Patients who received >3 days of treatment (n = 36) (n = 39)
 Treatment success at day 14 14 (38.9) 7 (17.9) .046
 HRS reversal 19 (52.8) 7 (17.9) .002